Visual pathway plays important role that receive, integrate and process visual information relay from the retina. Visual signals transmit information from retina to visual cortex for executive functioning and decision making. Damage in the visual pathway causes visual field defects including decline in cognition, memory loss and neurodegeneration. Degeneration of ganglion cells leads to disruption in signalling pathways affecting the visual mechanism and resulting in visual impairment and retinal degeneration. This makes it essential to understand how changes in the retina affect the functioning and information process downstream in visual cortex pathways (12).
Individuals with retinal degeneration show decreased visual cortex activity and elevated associative areas outside the visual field, like coordination of frontal and supplementary eye fields like prefrontal cortex and intraparietal sulcus. Though neuroplasticity is preserved during adulthood for functions like learning and memory, the absence of these experience-dependent changes has also been considered through the visual system, particularly the visual cortex. Evidence suggests that preserved visual plasticity has an influence on perceptual learning, short-term visual deprivation, progressive blinding pathologies and visual restoration therapies (13).
The various interventions (retinal prostheses and pharmacological manipulations) are implemented monocularly to deepen understanding of the mechanisms regulating adult visual plasticity that is critical for visual restoration in late-blind individuals. Theoretically, the restored monocular signals might be gated at the cortical level if ocular dominance plasticity cannot be endorsed (13). Although many studies have been done and attempting to treat retinal degeneration, a permanent cure for retinal degeneration is lacking.
Several surgical procedures such as vitrectomy, retinal sutures, prone air fluid exchange, retinal incarceration has been employed for the treatment of retinal detachment and other retinal disorders but the recovery rate is poor and patients still suffer from various side effects (14–16). Experimental and clinical studies have provided evidence that vascular endothelial growth factor (VEGF) is a major factor in promoting neovascularization (17–19). Understanding the mechanism of visual and cognitive functions provide evidence to explore disease pathophysiology. Therefore, we have investigated the role of laser injury on visual spatial memory and its rescue by stem cell transplantation.
Laser induced as a model to study retinal degeneration
Animal models for induced choroidal neovascularization (CNV) have been the backbone for testing new therapies. Laser induced mouse models have been frequently used to understand retinal degeneration pathophysiology (20–21). This model provides a reproducible platform for preclinical bio-therapeutic screening aided by laser photocoagulator. The laser-induced endothelial cell activation in a retinal vein occlusion disease model has also been studied (22). Therefore, laser-induced retinal injury mouse model was established to damage targeted sites in the retina (23) to study the therapeutic efficacy of lineage negative stem cells (Fig. 3) that may restore the visual memory and molecular pathway that cause retinal degeneration and visual impairment. Further, injury was confirmed by fundus fluoresceine angiography (Fig. 4). Moreover, FFA is one of the most important diagnostic criteria for investigating the retinal disease condition (24–26).
Confirmation and efficacy of Lineage Negative stem cells that may have neuroprotective activity
The stem cells have proven the principle of therapeutics and its effects in repairing RPE. Previously, the study has shown that Lin-ve cells migrate, integrate and survive more than three weeks in laser injured micro-environment (27). Further, the role of Lin-ve Bone marrow-derived stem cells in the N-methyl-D-aspartate (NMDA) induced RGC depletion model and retinal ischemia model was also studied (28). Lin-ve stem cells derived from umbilical cord blood have the potential to reverse the memory loss and enhance neurotrophic factor to clear Amyloid β plaques (29). In retinal degeneration model, the cells from ciliary epithelium were delivered under the neural retina at the photoreceptor-RPE interphase subretinal route that showed protective role (30). However, in none of these studies visual-spatial memory or cortical plasticity was studied. However, study reveals that the hUCB-derived mesenchymal stem cells differentiated into RPE-like cells with RPE-specific retinal markers at both the mRNA and protein level. Moreover, these cells possess phagocytic activity and ability to secrete neurotrophic factors, which are the key characteristics of endogenous RPE-like cells (31). With the information obtained from previous studies, the investigation was done to assess effect of laser induced retinal injury on visual memory and its restoration by lin-ve stem cell transplantation. Therefore, stem cells were transplanted into subretinal space (the space between the RPE and the outer nuclear layer). This area has been extensively manipulated for cell and graft transplantation as the closest site to the photoreceptors and the RPE and helps escape immune rejection (32).
Stem cells ameliorate the retinal injury and improvement in visual functions
With developments in stem cell biology, significant progress has been achieved in creating retinal cells in recent years. Pluripotent stem cells, including embryonic stem cells and induced pluripotent stem cells, can generate both sensory retinal neuron cells and retinal pigment epithelial cells in vitro (33). Retinal cell replacement using stem cell technology would be useful for restoring functioning retina, it has been used as a next-generation therapy for retinal degeneration (34–36). The number of studies have reported the efficacy of human stem cells in various animal models (37). The hUCB-derived cells were tested in rats, mice, and dogs, which were effective in brain disorders (37–38). The therapeutic effect of bone marrow mesenchymal stem cells on laser-induced retinal injury in mice, 1 × 106 MSCs in 200 µL PBS was administered intravenously via tail vein injection. The study found that MSC therapy might have a neuroprotective role in restoring visual functions (39). The role of adult bone marrow-derived Lin-HSCs in the rescue from retinal degenerative mouse models by intravitreal transplantation into rd and rd10 mouse models. Lin-HSC has substantial vasculotrophic and neurotrophic effects, which lasts up to 6 months after therapy and is most effective when Lin-HSCs are injected before total retinal degeneration (40).
Further, studies have demonstrated that subretinal transplantation of MSCs in RCS rats slows retinal degeneration and retains retinal function (41). The studies have defined the protective role of stem cells derived from different sources at a specific interval (42–44).
Shirai et al., 2016 demonstrated the competence of hESC-retina in monkey models that may be helpful in treatment for long-term, functional studies of retinal transplantation (45). However, the study has shown that bone marrow derived mononuclear stem cells have therapeutic potential to treat retinal degeneration as seen in two animal models with different etiologies such as the RCS and the P23H-1 rats (46).
We aimed to transplant a Lin-ve stem cell derived from hUCB in the laser induced retinal injury and probe its effect on visuospatial memory and assess the retinal and visual memory outcome after transplantation.
Association of retinal injury with Cognitive impairment
Studies have demonstrated the relation of cognitive impairment with injury severity, as cognitive defects increase with the increase in injury severity in TBI mice model. The injury created by us was categorised into mild, moderate, and severe and was evaluated on various neurobehavioral tests. It was found that resulting cognitive impairment analysed by Morris water maze increased with injury severity (47). The studies have provided evidence that injury interferes with visuospatial memory and it impacts life activity (48–50). However, studies have shown that hUCB-derived stem cell therapy is a promising experimental treatment of disease (51). Previous studies have shown that stem cell treatment improves cognition (52–53). The neuroprotective effect of hUCB-MSC was studied by stimulating microglial neuroinflammation, therefore ameliorating disease pathophysiology and reversing the cognitive loss associated with Aβ deposition in AD animals (54). Furthermore, our behavioural tests have revealed that hUCB Lin-ve therapy improved learning and memory impairments, indicating the recovery of behavioural function and molecular expression.
Similarly, passive avoidance, was done to measure learning and spatial memory. In 2 laser and 8 lasers, there was significant memory loss compared to the healthy group, as mice spent much less time in dark regions to avoid electric shock. Post transplantation group, it was found that in 2 lasers + stem cell and 8 lasers + stem cell group transplantation group have shown significant improvement in learning and memory retrieval behaviour and found to reverse memory loss in the passive avoidance test (Fig. 4.13). This implies that milder injury can be rescued by Lin-ve transplanted stem cells, whereas severe damage leads to more distortion in the retinal layer, which ultimately leads to disruption in retinal function and causes visual memory loss.
Therefore, in the present study, we determined the effects of hUCB-derived Lin-ve stem cells on retinal degeneration and the recovery of visual function after transplantation in a rodent model. Furthermore, our behavioral experiments show that treatment with hUCB Lin-ve stem cells can improve the performance in memory tasks (Fig. 19).
Thus, stem cells have potential to rescue from the damage and lead to an increase in the expression of neurotrophic factors. Studies have shown that BDNF, CNTF, bFGF (basic fibroblast growth factor) have neuroprotective effects and pro cell survival activity in retinal ischemia-induced rat models, these molecules interact with each other (55). Rhee et al., (2022) has shown that by boosting aerobic glycolysis and enhancing anabolic activities, CNTF considerably influences the metabolic state of degenerating retina. These results shed light on the molecular mechanisms causing increased neuronal survival and new treatments for retinal degeneration (56).
Furthermore, BDNF signalling is needed for both embryonic and adult neurogenesis and our findings suggest that treating with hUCB Lin-ve increases endogenous BDNF level as well as the restoration of behavioural function. Thus, our research establishes causal relationships between behavioural tasks and hUCB Lin-ve induced secreted BDNF signalling, which may initiate intracellular signalling in the retina, elevating BDNF expression and contributing to cognitive function recovery in the injury model (Fig. 19).
However, studies have shown that conventional approaches with endogenous growth factors enhance the effectiveness of stem cell therapy. Glial cells such as astrocytes, oligodendrocytes, and microglia are secreted all these factors play an important role in neurodevelopment, growth and survival as the brain develops. Endogenous neurotrophic factors such as glial cell-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), and nerve growth factor are expected to contribute to the support of the grafted nerve cells (57). Recent reports suggest that a novel small molecule BT13 binds RET to activate its downstream signaling cascades BT13 protects DA neurons from neurotoxin-induced cell death in vitro (58). Furthermore, BT13 activates DA signaling through RET and promotes DA release in the striatum in vivo, suggesting that BT13 is a candidate for the treatment of PD that may be suitable for cell removal excrete well and warrant further investigation (59). Advancement in stem cell biology and drug discovery has future insights. Although the studies have also shown that there is no need to repeat clinical trials in cell therapy without expansion. In fact, nothing new has been discovered about the safety or efficacy of stem cells after repeating clinical trials. Clinical trials should be conducted only on certain stem cell compounds, or in situations where the phenotype or genotype of stem cells may change (60)
Similarly, proliferative marker expression was analysed in the laser group and stem cell group (Fig. 4.18). It was found that retinal injury affects the proliferative ability and the expression of Ki67 was decreased in 2 laser injury i.e., mild injury and in 8 laser injury (severe injury), after stem cell transplantation in a respective group, it was found the expression was high as transplanted stem cells were able to proliferate in the surrounding environment (61).
Further, studies have demonstrated proliferative and differentiative properties of hUCB-derived stem cells (62). The VEGF protein level was compared with the injury group and stem cell. The effect of VEGF on retinal injury was found comparable.
Many studies have found that VEGF regulation is involved in disease progression, indicating that VEGFs secreted by cells initiate and promote pathological choroidal and retinal neovascularization processes in AMD (63).
At mRNA level, cell death markers were also analysed. The expression of Caspase 3 and GFAP was found significantly upregulated that indicates severe damage as compared to healthy control (Fig. 4.23 and 4.24). After stem cell transplantation, the expression was downregulated, which means the stem cell can rescue the damage and is better able to overcome retinal injury (Fig. 19). The present study has shown the involvement of astrocytes and Muller cells in the process. These results provide new insight into the gliosis-based mechanism in retinal degeneration regeneration.
Similarly, the RGC survival was analysed by Thy-1 expression, whose downregulation indicates loss of RGC in all degrees of injury as verified by immunohistochemistry (Fig. 4.25). This means that mild injury affects the retinal function and can be rescued by stem cell transplantation, as shown by recovery of lost RGC in the 2, 4 and 8 laser Lin-ve stem cell transplantation group. The therapeutic use of pluripotent cell-derived RGCs by grafting the cells in a healthy environment using suitable technological methods (64). The antiapoptotic marker BCL-2 was decreased in 2 lasers and 8 laser groups but the stem cell has shown improvement in the expression to indicate less cell death in 2 lasers + stem cell group and 8 laser stem cell group (Fig. 4.20). The studies have stem cells that can rescue the laser damage derived from bone marrow (65–66). Various studies have revealed that UCB-derived stem cells can proliferate into retinal cells that are further involved in repair mechanisms. The studies have shown that milder injury can be healed faster as compared to severe injury. Therefore, our research shows that stem cells could repair the damage and rescue the injury at a mild degree compared to severe injury (Fig. 19). The results suggest that stem cell therapy may induce a neuroprotective role in the rescue of retinal damage that restore visual function and visuospatial memory. UCB derived stem cells have good therapeutic effect in treating various clinical disorders (67–68)